|
1
|
Chen Y, Wu J, Liang G, Geng G, Zhao F, Yin
P, Nowsheen S, Wu C, Li Y, Li L, et al: CHK2-FOXK axis promotes
transcriptional control of autophagy programs. Sci Adv.
6:eaax58192020. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
He L, Gomes AP, Wang X, Yoon SO, Lee G,
Nagiec MJ, Cho S, Chavez A, Islam T, Yu Y, et al: mTORC1 promotes
metabolic reprogramming by the suppression of GSK3-dependent Foxk1
phosphorylation. Mol Cell. 70:949–960.e4. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hackmann K, Stadler A, Schallner J, Franke
K, Gerlach EM, Schrock E, Rump A, Fauth C, Tinschert S and Oexle K:
Severe intellectual disability, west syndrome, Dandy-Walker
malformation, and syndactyly in a patient with partial tetrasomy
17q25.3. Am J Med Genet A. 161A:3144–3149. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nestal de Moraes G, Carneiro LD, Maia RC,
Lam EW and Sharrocks AD: FOXK2 transcription factor and its
emerging roles in cancer. Cancers (Basel). 11:3932019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gitter A, Siegfried Z, Klutstein M, Fornes
O, Oliva B, Simon I and Bar-Joseph Z: Backup in gene regulatory
networks explains differences between binding and knockout results.
Mol Syst Biol. 5:2762009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dai Z, Dai X, Xiang Q and Feng J:
Robustness of transcriptional regulatory program influences gene
expression variability. BMC Genomics. 10:5732009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wu WS and Lai FJ: Functional redundancy of
transcription factors explains why most binding targets of a
transcription factor are not affected when the transcription factor
is knocked out. BMC Syst Biol. 9 (Suppl 6):S22015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hanahan D and Weinberg RA: The hallmarks
of cancer. Cell. 100:57–70. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hanahan D: Hallmarks of cancer: New
dimensions. Cancer Discov. 12:31–46. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kaestner KH, Knochel W and Martinez DE:
Unified nomenclature for the winged helix/forkhead transcription
factors. Genes Dev. 14:142–146. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lam EW, Brosens JJ, Gomes AR and Koo CY:
Forkhead box proteins: Tuning forks for transcriptional harmony.
Nat Rev Cancer. 13:482–495. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu Y, Ao X, Ding W, Ponnusamy M, Wu W,
Hao X, Yu W, Wang Y, Li P and Wang J: Critical role of FOXO3a in
carcinogenesis. Mol Cancer. 17:1042018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nakagawa S, Gisselbrecht SS, Rogers JM,
Hartl DL and Bulyk ML: DNA-binding specificity changes in the
evolution of forkhead transcription factors. Proc Natl Acad Sci
USA. 110:12349–12354. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li C, Lai CF, Sigman DS and Gaynor RB:
Cloning of a cellular factor, interleukin binding factor, that
binds to NFAT-like motifs in the human immunodeficiency virus long
terminal repeat. Proc Natl Acad Sci USA. 88:7739–7743. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Huang JT and Lee V: Identification and
characterization of a novel human FOXK1 gene in silico. Int
J Oncol. 25:751–757. 2004.PubMed/NCBI
|
|
17
|
Mahajan A, Yuan C, Lee H, Chen ES, Wu PY
and Tsai MD: Structure and function of the
phosphothreonine-specific FHA domain. Sci Signal. 1:re122008.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Durocher D and Jackson SP: The FHA domain.
FEBS Lett. 513:58–66. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Reinhardt HC and Yaffe MB:
Phospho-Ser/Thr-binding domains: Navigating the cell cycle and DNA
damage response. Nat Rev Mol Cell Biol. 14:563–580. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kalnina Z, Zayakin P, Silina K and Linē A:
Alterations of pre-mRNA splicing in cancer. Genes Chromosomes
Cancer. 42:342–357. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Roy M, Xu Q and Lee C: Evidence that
public database records for many cancer-associated genes reflect a
splice form found in tumors and lack normal splice forms. Nucleic
Acids Res. 33:5026–5033. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bates DO, Cui TG, Doughty JM, Winkler M,
Sugiono M, Shields JD, Peat D, Gillatt D and Harper SJ: VEGF165b,
an inhibitory splice variant of vascular endothelial growth factor,
is down-regulated in renal cell carcinoma. Cancer Res.
62:4123–4131. 2002.PubMed/NCBI
|
|
23
|
Hu Y, Fang C and Xu Y: The effect of
isoforms of the cell polarity protein, human ASIP, on the cell
cycle and Fas/FasL-mediated apoptosis in human hepatoma cells. Cell
Mol Life Sci. 62:1974–1983. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang L, Duke L, Zhang PS, Arlinghaus RB,
Symmans WF, Sahin A, Mendez R and Dai JL: Alternative splicing
disrupts a nuclear localization signal in spleen tyrosine kinase
that is required for invasion suppression in breast cancer. Cancer
Res. 63:4724–4730. 2003.PubMed/NCBI
|
|
25
|
Nirula A, Moore DJ and Gaynor RB:
Constitutive binding of the transcription factor interleukin-2
(IL-2) enhancer binding factor to the IL-2 promoter. J Biol Chem.
272:7736–7745. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Marais A, Ji Z, Child ES, Krause E, Mann
DJ and Sharrocks AD: Cell cycle-dependent regulation of the
forkhead transcription factor FOXK2 by CDK·cyclin complexes. J Biol
Chem. 285:35728–35739. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Pan Q, Shai O, Lee LJ, Frey BJ and
Blencowe BJ: Deep surveying of alternative splicing complexity in
the human transcriptome by high-throughput sequencing. Nat Genet.
40:1413–1415. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li C, Lusis AJ, Sparkes R, Nirula A and
Gaynor R: Characterization and chromosomal mapping of the gene
encoding the cellular DNA binding protein ILF. Genomics.
13:665–671. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang ET, Sandberg R, Luo S, Khrebtukova I,
Zhang L, Mayr C, Kingsmore SF, Schroth GP and Burge CB: Alternative
isoform regulation in human tissue transcriptomes. Nature.
456:470–476. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Merkin J, Russell C, Chen P and Burge CB:
Evolutionary dynamics of gene and isoform regulation in mammalian
tissues. Science. 338:1593–1599. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Climente-González H, Porta-Pardo E, Godzik
A and Eyras E: The functional impact of alternative splicing in
cancer. Cell Rep. 20:2215–2226. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang W, Li X, Lee M, Jun S, Aziz KE, Feng
L, Tran MK, Li N, McCrea PD, Park JI and Chen J: FOXKs promote
Wnt/β-catenin signaling by translocating DVL into the nucleus. Dev
Cell. 32:707–718. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liu Y, Ding W, Ge H, Ponnusamy M, Wang Q,
Hao X, Wu W, Zhang Y, Yu W, Ao X and Wang J: FOXK transcription
factors: Regulation and critical role in cancer. Cancer Lett.
458:1–12. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Giardina B, Messana I, Scatena R and
Castagnola M: The multiple functions of hemoglobin. Crit Rev
Biochem Mol Biol. 30:165–196. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Arbez N, Ratovitski T, Roby E, Chighladze
E, Stewart JC, Ren M, Wang X, Lavery DJ and Ross CA:
Post-translational modifications clustering within proteolytic
domains decrease mutant huntingtin toxicity. J Biol Chem.
292:19238–19249. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Snider NT and Omary MB: Post-translational
modifications of intermediate filament proteins: Mechanisms and
functions. Nat Rev Mol Cell Biol. 15:163–177. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Richard SA, Jiang Y, Xiang LH, Zhou S,
Wang J, Su Z and Xu H: Post-translational modifications of high
mobility group box 1 and cancer. Am J Transl Res. 9:5181–5196.
2017.PubMed/NCBI
|
|
38
|
Corujo D and Buschbeck M:
Post-translational modifications of H2A histone variants and their
role in cancer. Cancers (Basel). 10:592018. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Iavarone F, Desiderio C, Vitali A, Messana
I, Martelli C, Castagnola M and Cabras T: Cryptides: Latent
peptides everywhere. Crit Rev Biochem Mol Biol. 53:246–263. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Huang H, Arighi CN, Ross KE, Ren J, Li G,
Chen SC, Wang Q, Cowart J, Vijay-Shanker K and Wu CH: iPTMnet: An
integrated resource for protein post-translational modification
network discovery. Nucleic Acids Res. 46:D542–D550. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Yao B, Christian KM, He C, Jin P, Ming GL
and Song H: Epigenetic mechanisms in neurogenesis. Nat Rev
Neurosci. 17:537–549. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Liu MY, DeNizio JE, Schutsky EK and Kohli
RM: The expanding scope and impact of epigenetic cytosine
modifications. Curr Opin Chem Biol. 33:67–73. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Jones MJ, Goodman SJ and Kobor MS: DNA
methylation and healthy human aging. Aging Cell. 14:924–932. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Bird A: Perceptions of epigenetics.
Nature. 447:396–398. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Tsuchida T, Mano T, Koshi-Mano K, Bannai
T, Matsubara T, Yamashita S, Ushijima T, Nagata K, Murayama S, Toda
T, et al: Methylation changes and aberrant expression of FGFR3 in
Lewy body disease neurons. Brain Res. 1697:59–66. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Pan XY, Yang Y, Meng HW, Li HD, Chen X,
Huang HM, Bu FT, Yu HX, Wang Q, Huang C, et al: DNA methylation of
PTGIS enhances hepatic stellate cells activation and liver
fibrogenesis. Front Pharmacol. 9:5532018. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Hopp L, Löffler-Wirth H, Galle J and
Binder H: Combined SOM-portrayal of gene expression and DNA
methylation landscapes disentangles modes of epigenetic regulation
in glioblastoma. Epigenomics. 10:745–764. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Lopez-Serra P and Esteller M: DNA
methylation-associated silencing of tumor-suppressor microRNAs in
cancer. Oncogene. 31:1609–1622. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Le TN, Schumann U, Smith NA, Tiwari S, Au
PC, Zhu QH, Taylor JM, Kazan K, Llewellyn DJ, Zhang R, et al: DNA
demethylases target promoter transposable elements to positively
regulate stress responsive genes in Arabidopsis. Genome Biol.
15:4582014. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Jung M and Pfeifer GP: Aging and DNA
methylation. BMC Biol. 13:72015. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Bormann F, Rodríguez-Paredes M, Lasitschka
F, Edelmann D, Musch T, Benner A, Bergman Y, Dieter SM, Ball CR,
Glimm H, et al: Cell-of-Origin DNA methylation signatures are
maintained during colorectal carcinogenesis. Cell Rep.
23:3407–3418. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Jaenisch R and Bird A: Epigenetic
regulation of gene expression: How the genome integrates intrinsic
and environmental signals. Nat Genet. 33 (Suppl):S245–S254. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Egger G, Liang G, Aparicio A and Jones PA:
Epigenetics in human disease and prospects for epigenetic therapy.
Nature. 429:457–463. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Robertson KD: DNA methylation and human
disease. Nat Rev Genet. 6:597–610. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Bird A, Taggart M, Frommer M, Miller OJ
and Macleod D: A fraction of the mouse genome that is derived from
islands of nonmethylated, CpG-rich DNA. Cell. 40:91–99. 1985.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Goodrich JM, Furlong MA, Caban-Martinez
AJ, Jung AM, Batai K, Jenkins T, Beitel S, Littau S, Gulotta J,
Wallentine D, et al: Differential DNA methylation by hispanic
ethnicity among firefighters in the United States. Epigenet
Insights. Mar 26–2021.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Crujeiras AB, Pissios P, Moreno-Navarrete
JM, Diaz-Lagares A, Sandoval J, Gomez A, Ricart W, Esteller M,
Casanueva FF and Fernandez-Real JM: An epigenetic signature in
adipose tissue is linked to nicotinamide N-methyltransferase gene
expression. Mol Nutr Food Res. Apr 24–2018.(Epub ahead of print).
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Camprubí C, Salas-Huetos A, Aiese-Cigliano
R, Godo A, Pons MC, Castellano G, Grossmann M, Sanseverino W,
Martin-Subero JI, Garrido N and Blanco J: Spermatozoa from
infertile patients exhibit differences of DNA methylation
associated with spermatogenesis-related processes: An array-based
analysis. Reprod Biomed Online. 33:709–719. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Nwanaji-Enwerem JC, Jenkins TG, Colicino
E, Cardenas A, Baccarelli AA and Boyer EW: Serum dioxin levels and
sperm DNA methylation age: Findings in Vietnam war veterans exposed
to agent orange. Reprod Toxicol. 96:27–35. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Park SL, Patel YM, Loo LW, Mullen DJ,
Offringa IA, Maunakea A, Stram DO, Siegmund K, Murphy SE,
Tiirikainen M and Le Marchand L: Association of internal smoking
dose with blood DNA methylation in three racial/ethnic populations.
Clin Epigenetics. 10:1102018. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Yehuda R, Daskalakis NP, Bierer LM, Bader
HN, Klengel T, Holsboer F and Binder EB: Holocaust exposure induced
intergenerational effects on FKBP5 methylation. Biol Psychiatry.
80:372–380. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Hughes MF: Arsenic toxicity and potential
mechanisms of action. Toxicol Lett. 133:1–16. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Jones PA and Baylin SB: The fundamental
role of epigenetic events in cancer. Nat Rev Genet. 3:415–428.
2002. View
Article : Google Scholar : PubMed/NCBI
|
|
64
|
Jones PA and Baylin SB: The epigenomics of
cancer. Cell. 128:683–692. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Timbergen MJM, Boers R, Vriends ALM, Boers
J, van IJcken WFJ, Lavrijsen M, Grünhagen DJ, Verhoef C, Sleijfer
S, Smits R, et al: Differentially methylated regions in
desmoid-type fibromatosis: A comparison between CTNNB1 S45F and
T41A tumors. Front Oncol. 10:5650312020. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Spruijt CG, Gnerlich F, Smits AH,
Pfaffeneder T, Jansen PW, Bauer C, Münzel M, Wagner M, Müller M,
Khan F, et al: Dynamic readers for 5-(hydroxy)methylcytosine and
its oxidized derivatives. Cell. 152:1146–1159. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Iurlaro M, Ficz G, Oxley D, Raiber EA,
Bachman M, Booth MJ, Andrews S, Balasubramanian S and Reik W: A
screen for hydroxymethylcytosine and formylcytosine binding
proteins suggests functions in transcription and chromatin
regulation. Genome Biol. 14:R1192013. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Hu S, Wan J, Su Y, Song Q, Zeng Y, Nguyen
HN, Shin J, Cox E, Rho HS, Woodard C, et al: DNA methylation
presents distinct binding sites for human transcription factors.
Elife. 2:e007262013. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Baymaz HI, Fournier A, Laget S, Ji Z,
Jansen PW, Smits AH, Ferry L, Mensinga A, Poser I, Sharrocks A, et
al: MBD5 and MBD6 interact with the human PR-DUB complex through
their methyl-CpG-binding domain. Proteomics. 14:2179–2189. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Du Q, Luu PL, Stirzaker C and Clark SJ:
Methyl-CpG-binding domain proteins: Readers of the epigenome.
Epigenomics. 7:1051–1073. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Li X, Wilmanns M, Thornton J and Köhn M:
Elucidating human phosphatase-substrate networks. Sci Signal.
6:rs102013. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Sacco F, Perfetto L, Castagnoli L and
Cesareni G: The human phosphatase interactome: An intricate family
portrait. FEBS Lett. 586:2732–2739. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Fukami Y and Lipmann F: Reversal of Rous
sarcoma-specific immunoglobulin phosphorylation on tyrosine (ADP as
phosphate acceptor) catalyzed by the src gene kinase. Proc Natl
Acad Sci USA. 80:1872–1876. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Kole HK, Abdel-Ghany M and Racker E:
Specific dephosphorylation of phosphoproteins by protein-serine and
-tyrosine kinases. Proc Natl Acad Sci USA. 85:5849–5853. 1988.
View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Almawi AW, Matthews LA and Guarné A: FHA
domains: Phosphopeptide binding and beyond. Prog Biophys Mol Biol.
127:105–110. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Zhu G, Spellman PT, Volpe T, Brown PO,
Botstein D, Davis TN and Futcher B: Two yeast forkhead genes
regulate the cell cycle and pseudohyphal growth. Nature. 406:90–94.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Pic-Taylor A, Darieva Z, Morgan BA and
Sharrocks AD: Regulation of cell cycle-specific gene expression
through cyclin-dependent kinase-mediated phosphorylation of the
forkhead transcription factor Fkh2p. Mol Cell Biol. 24:10036–10046.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Ma RY, Tong TH, Cheung AM, Tsang AC, Leung
WY and Yao KM: Raf/MEK/MAPK signaling stimulates the nuclear
translocation and transactivating activity of FOXM1c. J Cell Sci.
118:795–806. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Myatt SS and Lam EW: The emerging roles of
forkhead box (Fox) proteins in cancer. Nat Rev Cancer. 7:847–859.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Li A, Wang J, Wu M, Zhang X and Zhang H:
The inhibition of activated hepatic stellate cells proliferation by
arctigenin through G0/G1 phase cell cycle arrest: Persistent
p27(Kip1) induction by interfering with PI3K/Akt/FOXO3a signaling
pathway. Eur J Pharmacol. 747:71–87. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Aitken A: 14-3-3 proteins: A historic
overview. Semin Cancer Biol. 16:162–172. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Nakatsumi H, Oka T, Higa T, Shirane M and
Nakayama KI: Nuclear-cytoplasmic shuttling protein PP2AB56
contributes to mTORC1-dependent dephosphorylation of FOXK1. Genes
Cells. 23:599–605. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Nakatsumi H, Matsumoto M and Nakayama KI:
Noncanonical pathway for regulation of CCL2 expression by an
mTORC1-FOXK1 axis promotes recruitment of tumor-associated
macrophages. Cell Rep. 21:2471–2486. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Sakaguchi M, Cai W, Wang CH, Cederquist
CT, Damasio M, Homan EP, Batista T, Ramirez AK, Gupta MK, Steger M,
et al: FoxK1 and FoxK2 in insulin regulation of cellular and
mitochondrial metabolism. Nat Commun. 10:15822019. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Amaya MJ, Oliveira AG, Guimarães ES,
Casteluber MC, Carvalho SM, Andrade LM, Pinto MC, Mennone A,
Oliveira CA, Resende RR, et al: The insulin receptor translocates
to the nucleus to regulate cell proliferation in liver. Hepatology.
59:274–283. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Katoh M and Katoh M: Identification and
characterization of human FOXK1 gene in silico. Int J Mol
Med. 14:127–132. 2004.PubMed/NCBI
|
|
87
|
Bowman CJ, Ayer DE and Dynlacht BD: Foxk
proteins repress the initiation of starvation-induced atrophy and
autophagy programs. Nat Cell Biol. 16:1202–1214. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Sukonina V, Ma H, Zhang W, Bartesaghi S,
Subhash S, Heglind M, Foyn H, Betz MJ, Nilsson D, Lidell ME, et al:
FOXK1 and FOXK2 regulate aerobic glycolysis. Nature. 566:279–283.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Xia YK, Zeng YR, Zhang ML, Liu P, Liu F,
Zhang H, He CX, Sun YP, Zhang JY, Zhang C, et al: Tumor-derived
neomorphic mutations in ASXL1 impairs the BAP1-ASXL1-FOXK1/K2
transcription network. Protein Cell. 12:557–577. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Danciu TE, Chupreta S, Cruz O, Fox JE,
Whitman M and Iñiguez-Lluhí JA: Small ubiquitin-like modifier
(SUMO) modification mediates function of the inhibitory domains of
developmental regulators FOXC1 and FOXC2. J Biol Chem.
287:18318–18329. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Sutinen P, Rahkama V, Rytinki M and
Palvimo JJ: Nuclear mobility and activity of FOXA1 with androgen
receptor are regulated by SUMOylation. Mol Endocrinol.
28:1719–1728. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Song JG, Xie HH, Li N, Wu K, Qiu JG, Shen
DM and Huang CJ: SUMO-specific protease 6 promotes gastric cancer
cell growth via deSUMOylation of FoxM1. Tumour Biol. 36:9865–9871.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Meredith LJ, Wang CM, Nascimento L, Liu R,
Wang L and Yang WH: The key regulator for language and speech
development, FOXP2, is a novel substrate for SUMOylation. J Cell
Biochem. 117:426–438. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Rocca DL, Wilkinson KA and Henley JM:
SUMOylation of FOXP1 regulates transcriptional repression via CtBP1
to drive dendritic morphogenesis. Sci Rep. 7:8772017. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Nestal de Moraes G, Ji Z, Fan LY, Yao S,
Zona S, Sharrocks AD and Lam EW: SUMOylation modulates
FOXK2-mediated paclitaxel sensitivity in breast cancer cells.
Oncogenesis. 7:292018. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Shmueli A and Oren M: Life, death and
ubiquitin: Taming the mule. Cell. 121:963–965. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
López-Otín C and Hunter T: The regulatory
crosstalk between kinases and proteases in cancer. Nat Rev Cancer.
10:278–292. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Ikeda F and Dikic I: Atypical ubiquitin
chains: New molecular signals. ‘Protein modifications: Beyond the
usual suspects’ review series. EMBO Rep. 9:536–542. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Suryadinata R, Roesley SN, Yang G and
Sarčević B: Mechanisms of generating polyubiquitin chains of
different topology. Cells. 3:674–689. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Rajalingam K and Dikic I: SnapShot:
Expanding the ubiquitin code. Cell. 164:1074–1074.e1. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Deng L, Meng T, Chen L, Wei W and Wang P:
The role of ubiquitination in tumorigenesis and targeted drug
discovery. Signal Transduct Target Ther. 5:112020. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Scheuermann JC, de Ayala Alonso AG, Oktaba
K, Ly-Hartig N, McGinty RK, Fraterman S, Wilm M, Muir TW and Müller
J: Histone H2A deubiquitinase activity of the polycomb repressive
complex PR-DUB. Nature. 465:243–247. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Abdel-Wahab O, Gao J, Adli M, Dey A,
Trimarchi T, Chung YR, Kuscu C, Hricik T, Ndiaye-Lobry D, Lafave
LM, et al: Deletion of Asxl1 results in myelodysplasia and severe
developmental defects in vivo. J Exp Med. 210:2641–2659. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
104
|
LaFave LM, Béguelin W, Koche R, Teater M,
Spitzer B, Chramiec A, Papalexi E, Keller MD, Hricik T,
Konstantinoff K, et al: Loss of BAP1 function leads to
EZH2-dependent transformation. Nat Med. 21:1344–1349. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Micol JB and Abdel-Wahab O: The role of
additional sex combs-like proteins in cancer. Cold Spring Harb
Perspect Med. 6:a0265262016. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Campagne A, Lee MK, Zielinski D, Michaud
A, Le Corre S, Dingli F, Chen H, Shahidian LZ, Vassilev I, Servant
N, et al: BAP1 complex promotes transcription by opposing
PRC1-mediated H2A ubiquitylation. Nat Commun. 10:3482019.
View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Ji Z, Mohammed H, Webber A, Ridsdale J,
Han N, Carroll JS and Sharrocks AD: The forkhead transcription
factor FOXK2 acts as a chromatin targeting factor for the
BAP1-containing histone deubiquitinase complex. Nucleic Acids Res.
42:6232–6242. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Abdel-Wahab O and Dey A: The ASXL-BAP1
axis: New factors in myelopoiesis, cancer and epigenetics.
Leukemia. 27:10–15. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Carbone M, Yang H, Pass HI, Krausz T,
Testa JR and Gaudino G: BAP1 and cancer. Nat Rev Cancer.
13:153–159. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Chittock EC, Latwiel S, Miller TC and
Müller CW: Molecular architecture of polycomb repressive complexes.
Biochem Soc Trans. 45:193–205. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Okino Y, Machida Y, Frankland-Searby S and
Machida YJ: BRCA1-associated protein 1 (BAP1) deubiquitinase
antagonizes the ubiquitin-mediated activation of FoxK2 target
genes. J Biol Chem. 290:1580–1591. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Ivanov GS, Ivanova T, Kurash J, Ivanov A,
Chuikov S, Gizatullin F, Herrera-Medina EM, Rauscher F III,
Reinberg D and Barlev NA: Methylation-acetylation interplay
activates p53 in response to DNA damage. Mol Cell Biol.
27:6756–6769. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Li G, Margueron R, Hu G, Stokes D, Wang YH
and Reinberg D: Highly compacted chromatin formed in vitro reflects
the dynamics of transcription activation in vivo. Mol Cell.
38:41–53. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Wang XW, Guo QQ, Yu Y, Zhou TT, Zhang SY,
Wang Z, Liu JW, Tang J, Jiang XY, Wang SS, et al: The deacetylation
of Foxk2 by Sirt1 reduces chemosensitivity to cisplatin. J Cell Mol
Med. 26:491–506. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Bejerano G, Pheasant M, Makunin I, Stephen
S, Kent WJ, Mattick JS and Haussler D: Ultraconserved elements in
the human genome. Science. 304:1321–1325. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Johnsson P, Lipovich L, Grandér D and
Morris KV: Evolutionary conservation of long non-coding RNAs;
sequence, structure, function. Biochim Biophys Acta.
1840:1063–1071. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Cech TR and Steitz JA: The noncoding RNA
revolution-trashing old rules to forge new ones. Cell. 157:77–94.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Kentwell J, Gundara JS and Sidhu SB:
Noncoding RNAs in endocrine malignancy. Oncologist. 19:483–491.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Lieberman J: Tapping the RNA world for
therapeutics. Nat Struct Mol Biol. 25:357–364. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Gomes CPC, Schroen B, Kuster GM, Robinson
EL, Ford K, Squire IB, Heymans S, Martelli F, Emanueli C and Devaux
Y; EU-CardioRNA COST Action (CA17129), : Regulatory RNAs in heart
failure. Circulation. 141:313–328. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Ebert MS and Sharp PA: Roles for microRNAs
in conferring robustness to biological processes. Cell.
149:515–524. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Yamamura S, Imai-Sumida M, Tanaka Y and
Dahiya R: Interaction and cross-talk between non-coding RNAs. Cell
Mol Life Sci. 75:467–484. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Anastasiadou E, Jacob LS and Slack FJ:
Non-coding RNA networks in cancer. Nat Rev Cancer. 18:5–18. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Fabian MR, Mathonnet G, Sundermeier T,
Mathys H, Zipprich JT, Svitkin YV, Rivas F, Jinek M, Wohlschlegel
J, Doudna JA, et al: Mammalian miRNA RISC recruits CAF1 and PABP to
affect PABP-dependent deadenylation. Mol Cell. 35:868–880. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Min KW, Jo MH, Shin S, Davila S, Zealy RW,
Kang SI, Lloyd LT, Hohng S and Yoon JH: AUF1 facilitates
microRNA-mediated gene silencing. Nucleic Acids Res. 45:6064–6073.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Sun M, Ding J, Li D, Yang G, Cheng Z and
Zhu Q: NUDT21 regulates 3′-UTR length and microRNA-mediated gene
silencing in hepatocellular carcinoma. Cancer Lett. 410:158–168.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Chen D, Wang H, Chen J, Li Z, Li S, Hu Z,
Huang S, Zhao Y and He X: MicroRNA-129-5p regulates glycolysis and
cell proliferation by targeting the glucose transporter SLC2A3 in
gastric cancer cells. Front Pharmacol. 9:5022018. View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Cui Z, Liu L, Kwame Amevor F, Zhu Q, Wang
Y, Li D, Shu G, Tian Y and Zhao X: High expression of miR-204 in
chicken atrophic ovaries promotes granulosa cell apoptosis and
inhibits autophagy. Front Cell Dev Biol. 8:5800722020. View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Lin MF, Yang YF, Peng ZP, Zhang MF, Liang
JY, Chen W, Liu XH and Zheng YL: FOXK2, regulted by miR-1271-5p,
promotes cell growth and indicates unfavorable prognosis in
hepatocellular carcinoma. Int J Biochem Cell Biol. 88:155–161.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Chen S, Jiang S, Hu F, Xu Y, Wang T and
Mei Q: Foxk2 inhibits non-small cell lung cancer
epithelial-mesenchymal transition and proliferation through the
repression of different key target genes. Oncol Rep. 37:2335–2347.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Harada K, Baba Y, Ishimoto T, Shigaki H,
Kosumi K, Yoshida N, Watanabe M and Baba H: The role of microRNA in
esophageal squamous cell carcinoma. J Gastroenterol. 51:520–530.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
134
|
Liu M, Yu J, Wang D, Niu Y, Chen S, Gao P,
Yang Z, Wang H, Zhang J, Zhang C, et al: Epigenetically upregulated
MicroRNA-602 is involved in a negative feedback loop with FOXK2 in
esophageal squamous cell carcinoma. Mol Ther. 27:1796–1809. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
135
|
Wang D, Wang H, Liu C, Mu X and Cheng S:
Hyperglycemia inhibition of endothelial miR-140-3p mediates
angiogenic dysfunction in diabetes mellitus. J Diabetes
Complications. 33:374–382. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Li S, Zhao L, Li X, Shang G, Gao L, Song Z
and Li T: Mir-204 regulates LPS-induced A549 cell damage by
targeting FOXK2. J Healthc Eng. 2021:74046712021. View Article : Google Scholar : PubMed/NCBI
|
|
137
|
Kristensen LS, Andersen MS, Stagsted LVW,
Ebbesen KK, Hansen TB and Kjems J: The biogenesis, biology and
characterization of circular RNAs. Nat Rev Genet. 20:675–691. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
138
|
Chen LL: The expanding regulatory
mechanisms and cellular functions of circular RNAs. Nat Rev Mol
Cell Biol. 21:475–490. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
139
|
Ashwal-Fluss R, Meyer M, Pamudurti NR,
Ivanov A, Bartok O, Hanan M, Evantal N, Memczak S, Rajewsky N and
Kadener S: circRNA biogenesis competes with pre-mRNA splicing. Mol
Cell. 56:55–66. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
140
|
Kristensen LS, Hansen TB, Venø MT and
Kjems J: Circular RNAs in cancer: Opportunities and challenges in
the field. Oncogene. 37:555–565. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
141
|
Patop IL and Kadener S: circRNAs in
cancer. Curr Opin Genet Dev. 48:121–127. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
142
|
Zhang M and Xin Y: Circular RNAs: A new
frontier for cancer diagnosis and therapy. J Hematol Oncol.
11:212018. View Article : Google Scholar : PubMed/NCBI
|
|
143
|
Hansen TB, Jensen TI, Clausen BH, Bramsen
JB, Finsen B, Damgaard CK and Kjems J: Natural RNA circles function
as efficient microRNA sponges. Nature. 495:384–388. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
144
|
Memczak S, Jens M, Elefsinioti A, Torti F,
Krueger J, Rybak A, Maier L, Mackowiak SD, Gregersen LH, Munschauer
M, et al: Circular RNAs are a large class of animal RNAs with
regulatory potency. Nature. 495:333–338. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
145
|
Hu W, Bi ZY, Chen ZL, Liu C, Li LL, Zhang
F, Zhou Q, Zhu W, Song YY, Zhan BT, et al: Emerging landscape of
circular RNAs in lung cancer. Cancer Lett. 427:18–27. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
146
|
Hua Q, Chen Y, Liu Y, Li M, Diao Q, Xue H,
Zeng H, Huang L and Jiang Y: Circular RNA 0039411 is involved in
neodymium oxide-induced inflammation and antiproliferation in a
human bronchial epithelial cell line via sponging miR-93-5p.
Toxicol Sci. 170:69–81. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
147
|
Han D, Wang Y, Wang Y, Dai X, Zhou T, Chen
J, Tao B, Zhang J and Cao F: The tumor-suppressive human circular
RNA CircITCH sponges miR-330-5p to ameliorate doxorubicin-induced
cardiotoxicity through upregulating SIRT6, survivin and SERCA2a.
Circ Res. 127:e108–e125. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
148
|
Yang C, Yuan W, Yang X, Li P, Wang J, Han
J, Tao J, Li P, Yang H, Lv Q and Zhang W: Circular RNA circ-ITCH
inhibits bladder cancer progression by sponging miR-17/miR-224 and
regulating p21, PTEN expression. Mol Cancer. 17:192018. View Article : Google Scholar : PubMed/NCBI
|
|
149
|
Li J, Guo R, Liu Q, Sun J and Wang H:
Circular RNA Circ-ITCH inhibits the malignant behaviors of cervical
cancer by microRNA-93-5p/FOXK2 axis. Reprod Sci. 27:860–868. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
150
|
Shi X, Liu TT, Yu XN, Balakrishnan A, Zhu
HR, Guo HY, Zhang GC, Bilegsaikhan E, Sun JL, Song GQ, et al:
microRNA-93-5p promotes hepatocellular carcinoma progression via a
microRNA-93-5p/MAP3K2/c-Jun positive feedback circuit. Oncogene.
39:5768–5781. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
151
|
Ma DH, Li BS, Liu JJ, Xiao YF, Yong X,
Wang SM, Wu YY, Zhu HB, Wang DX and Yang SM: miR-93-5p/IFNAR1 axis
promotes gastric cancer metastasis through activating the STAT3
signaling pathway. Cancer Lett. 408:23–32. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
152
|
Chen X, Chen S, Xiu YL, Sun KX, Zong ZH
and Zhao Y: RhoC is a major target of microRNA-93-5P in epithelial
ovarian carcinoma tumorigenesis and progression. Mol Cancer.
14:312015. View Article : Google Scholar : PubMed/NCBI
|
|
153
|
Li J, Chu ZP, Han H, Zhang Y, Tian F,
Zhang JQ and Huang XH: Suppression of miR-93-5p inhibits high-risk
HPV-positive cervical cancer progression via targeting of BTG3. Hum
Cell. 32:160–171. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
154
|
Li Y, Ge YZ, Xu L and Jia R: Circular RNA
ITCH: A novel tumor suppressor in multiple cancers. Life Sci.
254:1171762020. View Article : Google Scholar : PubMed/NCBI
|
|
155
|
Sun J, Yin A, Zhang W, Lv J, Liang Y, Li
H, Li Y and Li X: CircUBAP2 inhibits proliferation and metastasis
of clear cell renal cell carcinoma via targeting miR-148a-3p/FOXK2
pathway. Cell Transplant. 29:9636897209257512020. View Article : Google Scholar : PubMed/NCBI
|
|
156
|
Xu Q, Cheng D, Li G, Liu Y, Li P, Sun W,
Ma D and Ni C: CircHIPK3 regulates pulmonary fibrosis by
facilitating glycolysis in miR-30a-3p/FOXK2-dependent manner. Int J
Biol Sci. 17:2294–2307. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
157
|
Iyer MK, Niknafs YS, Malik R, Singhal U,
Sahu A, Hosono Y, Barrette TR, Prensner JR, Evans JR, Zhao S, et
al: The landscape of long noncoding RNAs in the human
transcriptome. Nat Genet. 47:199–208. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
158
|
St Laurent G, Wahlestedt C and Kapranov P:
The landscape of long noncoding RNA classification. Trends Genet.
31:239–251. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
159
|
Kitagawa M, Kitagawa K, Kotake Y, Niida H
and Ohhata T: Cell cycle regulation by long non-coding RNAs. Cell
Mol Life Sci. 70:4785–4794. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
160
|
Ballarino M, Morlando M, Fatica A and
Bozzoni I: Non-coding RNAs in muscle differentiation and
musculoskeletal disease. J Clin Invest. 126:2021–2030. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
161
|
Brazão TF, Johnson JS, Müller J, Heger A,
Ponting CP and Tybulewicz VL: Long noncoding RNAs in B-cell
development and activation. Blood. 128:e10–e19. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
162
|
Delás MJ, Sabin LR, Dolzhenko E, Knott SR,
Munera Maravilla E, Jackson BT, Wild SA, Kovacevic T, Stork EM,
Zhou M, et al: lncRNA requirements for mouse acute myeloid leukemia
and normal differentiation. Elife. 6:e256072017. View Article : Google Scholar : PubMed/NCBI
|
|
163
|
Sirey TM, Roberts K, Haerty W,
Bedoya-Reina O, Rogatti-Granados S, Tan JY, Li N, Heather LC,
Carter RN, Cooper S, et al: The long non-coding RNA Cerox1 is a
post transcriptional regulator of mitochondrial complex I catalytic
activity. Elife. 8:e450512019. View Article : Google Scholar : PubMed/NCBI
|
|
164
|
Esteller M: Non-coding RNAs in human
disease. Nat Rev Genet. 12:861–874. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
165
|
Yuan JH, Yang F, Wang F, Ma JZ, Guo YJ,
Tao QF, Liu F, Pan W, Wang TT, Zhou CC, et al: A long noncoding RNA
activated by TGF-β promotes the invasion-metastasis cascade in
hepatocellular carcinoma. Cancer Cell. 25:666–681. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
166
|
Huarte M: The emerging role of lncRNAs in
cancer. Nat Med. 21:1253–1261. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
167
|
Liao D, Liu X, Yuan X, Feng P, Ouyang Z,
Liu Y and Li C: Long non-coding RNA tumor protein 53 target gene 1
promotes cervical cancer development via regulating microRNA-33a-5p
to target forkhead box K2. Cell Cycle. 21:572–584. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
168
|
Diaz-Lagares A, Crujeiras AB, Lopez-Serra
P, Soler M, Setien F, Goyal A, Sandoval J, Hashimoto Y,
Martinez-Cardús A, Gomez A, et al: Epigenetic inactivation of the
p53-induced long noncoding RNA TP53 target 1 in human cancer. Proc
Natl Acad Sci USA. 113:E7535–E7544. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
169
|
Chen B, Lan J, Xiao Y, Liu P, Guo D, Gu Y,
Song Y, Zhong Q, Ma D, Lei P and Liu Q: Long noncoding RNA TP53TG1
suppresses the growth and metastasis of hepatocellular carcinoma by
regulating the PRDX4/β-catenin pathway. Cancer Lett. 513:75–89.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
170
|
Pan J, Fang S, Tian H, Zhou C, Zhao X,
Tian H, He J, Shen W, Meng X, Jin X and Gong Z: lncRNA
JPX/miR-33a-5p/Twist1 axis regulates tumorigenesis and metastasis
of lung cancer by activating Wnt/β-catenin signaling. Mol Cancer.
19:92020. View Article : Google Scholar : PubMed/NCBI
|
|
171
|
Lin C, Xiang Y, Sheng J, Liu S, Cui M and
Zhang X: Long non-coding RNA CRNDE promotes malignant progression
of hepatocellular carcinoma through the miR-33a-5p/CDK6 axis. J
Physiol Biochem. 76:469–481. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
172
|
Sasaki M, Ishikawa T, Ishiguro M, Okazaki
S, Yamauchi S, Kikuchi A, Matsuyama T, Kawada K, Tokunaga M, Uetake
H and Kinugasa Y: The effectiveness of plasma miR-33a-5p as a
predictive biomarker for the efficacy of colorectal cancer
chemotherapy. Oncol Lett. 21:4892021. View Article : Google Scholar : PubMed/NCBI
|
|
173
|
Zhao Z, Gao J and Huang S: LncRNA SNHG7
promotes the HCC progression through miR-122-5p/FOXK2 axis. Dig Dis
Sci. 67:925–935. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
174
|
van der Heide LP, Wijchers PJ, von Oerthel
L, Burbach JP, Hoekman MF and Smidt MP: FoxK2 is required for
cellular proliferation and survival. J Cell Physiol. 230:1013–1023.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
175
|
Qian Y, Xia S and Feng Z: Sox9 mediated
transcriptional activation of FOXK2 is critical for colorectal
cancer cells proliferation. Biochem Biophys Res Commun.
483:475–481. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
176
|
Ji Z, Donaldson IJ, Liu J, Hayes A, Zeef
LA and Sharrocks AD: The forkhead transcription factor FOXK2
promotes AP-1-mediated transcriptional regulation. Mol Cell Biol.
32:385–398. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
177
|
Meehan RR, Lewis JD, McKay S, Kleiner EL
and Bird AP: Identification of a mammalian protein that binds
specifically to DNA containing methylated CpGs. Cell. 58:499–507.
1989. View Article : Google Scholar : PubMed/NCBI
|
|
178
|
Hendrich B and Bird A: Identification and
characterization of a family of mammalian methyl-CpG binding
proteins. Mol Cell Biol. 18:6538–6547. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
179
|
Chen X, Ji Z, Webber A and Sharrocks AD:
Genome-wide binding studies reveal DNA binding specificity
mechanisms and functional interplay amongst forkhead transcription
factors. Nucleic Acids Res. 44:1566–1578. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
180
|
Komorek J, Kuppuswamy M, Subramanian T,
Vijayalingam S, Lomonosova E, Zhao LJ, Mymryk JS, Schmitt K and
Chinnadurai G: Adenovirus type 5 E1A and E6 proteins of low-risk
cutaneous beta-human papillomaviruses suppress cell transformation
through interaction with FOXK1/K2 transcription factors. J Virol.
84:2719–2731. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
181
|
Tang F, Cao F, Lu C, He X, Weng L and Sun
L: Dvl2 facilitates the coordination of NF-κB and Wnt signaling to
promote colitis-associated colorectal progression. Cancer Sci.
113:565–575. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
182
|
Good MC, Zalatan JG and Lim WA: Scaffold
proteins: Hubs for controlling the flow of cellular information.
Science. 332:680–686. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
183
|
Pan CQ, Sudol M, Sheetz M and Low BC:
Modularity and functional plasticity of scaffold proteins as
p(l)acemakers in cell signaling. Cell Signal. 24:2143–2165. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
184
|
Kagan JC, Magupalli VG and Wu H: SMOCs:
Supramolecular organizing centres that control innate immunity. Nat
Rev Immunol. 14:821–826. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
185
|
Langeberg LK and Scott JD: Signalling
scaffolds and local organization of cellular behaviour. Nat Rev Mol
Cell Biol. 16:232–244. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
186
|
Liu Y, Ao X, Jia Z, Bai XY, Xu Z, Hu G,
Jiang X, Chen M and Wu H: FOXK2 transcription factor suppresses
ERα-positive breast cancer cell growth through down-regulating the
stability of ERα via mechanism involving BRCA1/BARD1. Sci Rep.
5:87962015. View Article : Google Scholar : PubMed/NCBI
|
|
187
|
Parsons R, Li GM, Longley MJ, Fang WH,
Papadopoulos N, Jen J, de la Chapelle A, Kinzler KW, Vogelstein B
and Modrich P: Hypermutability and mismatch repair deficiency in
RER+ tumor cells. Cell. 75:1227–1236. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
188
|
Fishel R, Lescoe MK, Rao MR, Copeland NG,
Jenkins NA, Garber J, Kane M and Kolodner R: The human mutator gene
homolog MSH2 and its association with hereditary nonpolyposis colon
cancer. Cell. 75:1027–1038. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
189
|
Leach FS, Nicolaides NC, Papadopoulos N,
Liu B, Jen J, Parsons R, Peltomäki P, Sistonen P, Aaltonen LA,
Nyström-Lahti M, et al: Mutations of a mutS homolog in hereditary
nonpolyposis colorectal cancer. Cell. 75:1215–1225. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
190
|
Katoh M, Igarashi M, Fukuda H, Nakagama H
and Katoh M: Cancer genetics and genomics of human FOX family
genes. Cancer Lett. 328:198–206. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
191
|
Michailidou K, Lindström S, Dennis J,
Beesley J, Hui S, Kar S, Lemaçon A, Soucy P, Glubb D, Rostamianfar
A, et al: Association analysis identifies 65 new breast cancer risk
loci. Nature. 551:92–94. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
192
|
Fujii Y and Nakamura M: FOXK2
transcription factor is a novel G/T-mismatch DNA binding protein. J
Biochem. 147:705–709. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
193
|
Zhang F, Ma X, Li H, Zhang Y, Li X, Chen
L, Guo G, Gao Y, Gu L, Xie Y, et al: FOXK2 suppresses the malignant
phenotype and induces apoptosis through inhibition of EGFR in
clear-cell renal cell carcinoma. Int J Cancer. 142:2543–2557. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
194
|
Shan L, Zhou X, Liu X, Wang Y, Su D, Hou
Y, Yu N, Yang C, Liu B, Gao J, et al: FOXK2 elicits massive
transcription repression and suppresses the hypoxic response and
breast cancer carcinogenesis. Cancer Cell. 30:708–722. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
195
|
Wang B, Zhang X, Wang W, Zhu Z, Tang F,
Wang D, Liu X, Zhuang H and Yan X: Forkhead box K2 inhibits the
proliferation, migration, and invasion of human glioma cells and
predicts a favorable prognosis. Onco Targets Ther. 11:1067–1075.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
196
|
Li S, Wang P, Ju H, Zhu T, Shi J and Huang
Y: FOXK2 promotes the proliferation of papillary thyroid cancer
cell by down-regulating autophagy. J Cancer. 13:858–868. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
197
|
Feng H, Jin Z, Liang J, Zhao Q, Zhan L,
Yang Z, Yan J, Kuang J, Cheng X and Qiu W: FOXK2 transcriptionally
activating VEGFA induces apatinib resistance in anaplastic thyroid
cancer through VEGFA/VEGFR1 pathway. Oncogene. 40:6115–6129. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
198
|
Du F, Qiao C, Li X, Chen Z, Liu H, Wu S,
Hu S, Qiu Z, Qian M, Tian D, et al: Forkhead box K2 promotes human
colorectal cancer metastasis by upregulating ZEB1 and EGFR.
Theranostics. 9:3879–3902. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
199
|
Baylin SB and Jones PA: Epigenetic
determinants of cancer. Cold Spring Harb Perspect Biol.
8:a0195052016. View Article : Google Scholar : PubMed/NCBI
|
|
200
|
Jones PA, Issa JP and Baylin S: Targeting
the cancer epigenome for therapy. Nat Rev Genet. 17:630–641. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
201
|
Block KI, Gyllenhaal C, Lowe L, Amedei A,
Amin AR, Amin A, Aquilano K, Arbiser J, Arreola A, Arzumanyan A, et
al: Designing a broad-spectrum integrative approach for cancer
prevention and treatment. Semin Cancer Biol. 35 (Suppl
1):S276–S304. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
202
|
Duijf PHG, Nanayakkara D, Nones K, Srihari
S, Kalimutho M and Khanna KK: Mechanisms of genomic instability in
breast cancer. Trends Mol Med. 25:595–611. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
203
|
Rusin M, Zajkowicz A and Butkiewicz D:
Resveratrol induces senescence-like growth inhibition of U-2 OS
cells associated with the instability of telomeric DNA and
upregulation of BRCA1. Mech Ageing Dev. 130:528–537. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
204
|
Falck J, Mailand N, Syljuåsen RG, Bartek J
and Lukas J: The ATM-Chk2-Cdc25A checkpoint pathway guards against
radioresistant DNA synthesis. Nature. 410:842–847. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
205
|
Matsuoka S, Huang M and Elledge SJ:
Linkage of ATM to cell cycle regulation by the Chk2 protein kinase.
Science. 282:1893–1897. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
206
|
Mas-Ponte D and Supek F: DNA mismatch
repair promotes APOBEC3-mediated diffuse hypermutation in human
cancers. Nat Genet. 52:958–968. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
207
|
Barroso-Sousa R, Jain E, Cohen O, Kim D,
Buendia-Buendia J, Winer E, Lin N, Tolaney SM and Wagle N:
Prevalence and mutational determinants of high tumor mutation
burden in breast cancer. Ann Oncol. 31:387–394. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
208
|
LeBlanc SJ, Gauer JW, Hao P, Case BC,
Hingorani MM, Weninger KR and Erie DA: Coordinated protein and DNA
conformational changes govern mismatch repair initiation by MutS.
Nucleic Acids Res. 46:10782–10795. 2018.PubMed/NCBI
|
|
209
|
Yu H, Pak H, Hammond-Martel I, Ghram M,
Rodrigue A, Daou S, Barbour H, Corbeil L, Hébert J, Drobetsky E, et
al: Tumor suppressor and deubiquitinase BAP1 promotes DNA
double-strand break repair. Proc Natl Acad Sci USA. 111:285–290.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
210
|
Kundert K and Fraser JS: DNA-binding
proteins meet their mismatch. Nature. 587:199–200. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
211
|
Li J, Coïc E, Lee K, Lee CS, Kim JA, Wu Q
and Haber JE: Regulation of budding yeast mating-type switching
donor preference by the FHA domain of Fkh1. PLoS Genet.
8:e10026302012. View Article : Google Scholar : PubMed/NCBI
|
|
212
|
Maciejowski J and de Lange T: Telomeres in
cancer: Tumour suppression and genome instability. Nat Rev Mol Cell
Biol. 18:175–186. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
213
|
Chakravarti D, LaBella KA and DePinho RA:
Telomeres: History, health and hallmarks of aging. Cell.
184:306–322. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
214
|
Tang M, Feng X, Pei G, Srivastava M, Wang
C, Chen Z, Li S, Zhang H, Zhao Z, Li X and Chen J: FOXK1
participates in DNA damage response by controlling 53BP1 function.
Cell Rep. 32:1080182020. View Article : Google Scholar : PubMed/NCBI
|
|
215
|
Lichtenstein P, Holm NV, Verkasalo PK,
Iliadou A, Kaprio J, Koskenvuo M, Pukkala E, Skytthe A and Hemminki
K: Environmental and heritable factors in the causation of
cancer-analyses of cohorts of twins from Sweden, Denmark, and
Finland. N Engl J Med. 343:78–85. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
216
|
Berdasco M and Esteller M: Aberrant
epigenetic landscape in cancer: How cellular identity goes awry.
Dev Cell. 19:698–711. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
217
|
Esteller M: Cancer epigenomics: DNA
methylomes and histone-modification maps. Nat Rev Genet. 8:286–298.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
218
|
Bitman-Lotan E and Orian A: Nuclear
organization and regulation of the differentiated state. Cell Mol
Life Sci. 78:3141–3158. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
219
|
Goldberg AD, Allis CD and Bernstein E:
Epigenetics: A landscape takes shape. Cell. 128:635–638. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
220
|
Nam AS, Chaligne R and Landau DA:
Integrating genetic and non-genetic determinants of cancer
evolution by single-cell multi-omics. Nat Rev Genet. 22:3–18. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
221
|
Feng Y, Liu X and Pauklin S: 3D chromatin
architecture and epigenetic regulation in cancer stem cells.
Protein Cell. 12:440–454. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
222
|
Toh TB, Lim JJ and Chow EK: Epigenetics in
cancer stem cells. Mol Cancer. 16:292017. View Article : Google Scholar : PubMed/NCBI
|
|
223
|
Dvorak HF: Tumors: Wounds that do not
heal. Similarities between tumor stroma generation and wound
healing. N Engl J Med. 315:1650–1659. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
224
|
Mantovani A, Allavena P, Sica A and
Balkwill F: Cancer-related inflammation. Nature. 454:436–444. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
225
|
Pagès F, Galon J, Dieu-Nosjean MC, Tartour
E, Sautès-Fridman C and Fridman WH: Immune infiltration in human
tumors: A prognostic factor that should not be ignored. Oncogene.
29:1093–1102. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
226
|
Grivennikov SI, Greten FR and Karin M:
Immunity, inflammation, and cancer. Cell. 140:883–899. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
227
|
Qian BZ and Pollard JW: Macrophage
diversity enhances tumor progression and metastasis. Cell.
141:39–51. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
228
|
van Bilsen JHM, Dulos R, van Stee MF,
Meima MY, Rouhani Rankouhi T, Neergaard Jacobsen L, Staudt
Kvistgaard A, Garthoff JA, Knippels LMJ, Knipping K, et al: Seeking
windows of opportunity to shape lifelong immune health: A
network-based strategy to predict and prioritize markers of early
life immune modulation. Front Immunol. 11:6442020. View Article : Google Scholar : PubMed/NCBI
|
|
229
|
Oh H and Ghosh S: NF-κB: Roles and
regulation in different CD4(+) T-cell subsets. Immunol Rev.
252:41–51. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
230
|
Blanchett S, Boal-Carvalho I, Layzell S
and Seddon B: NF-κB and extrinsic cell death pathways-entwined
do-or-die decisions for T cells. Trends Immunol. 42:76–88. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
231
|
Gilmore TD: Introduction to NF-kappaB:
Players, pathways, perspectives. Oncogene. 25:6680–6684. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
232
|
Karin M and Greten FR: NF-kappaB: Linking
inflammation and immunity to cancer development and progression.
Nat Rev Immunol. 5:749–759. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
233
|
Li Q, Withoff S and Verma IM:
Inflammation-associated cancer: NF-kappaB is the lynchpin. Trends
Immunol. 26:318–325. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
234
|
DeNardo DG, Andreu P and Coussens LM:
Interactions between lymphocytes and myeloid cells regulate
pro-versus anti-tumor immunity. Cancer Metastasis Rev. 29:309–316.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
235
|
Ohnishi S, Ma N, Thanan R, Pinlaor S,
Hammam O, Murata M and Kawanishi S: DNA damage in
inflammation-related carcinogenesis and cancer stem cells. Oxid Med
Cell Longev. 2013:3870142013. View Article : Google Scholar : PubMed/NCBI
|
|
236
|
Martin TD, Patel RS, Cook DR, Choi MY,
Patil A, Liang AC, Li MZ, Haigis KM and Elledge SJ: The adaptive
immune system is a major driver of selection for tumor suppressor
gene inactivation. Science. 373:1327–1335. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
237
|
Sepich-Poore GD, Zitvogel L, Straussman R,
Hasty J, Wargo JA and Knight R: The microbiome and human cancer.
Science. 371:eabc45522021. View Article : Google Scholar : PubMed/NCBI
|
|
238
|
Gopalakrishnan V, Helmink BA, Spencer CN,
Reuben A and Wargo JA: The influence of the gut microbiome on
cancer, immunity, and cancer immunotherapy. Cancer Cell.
33:570–580. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
239
|
Rowe WP, Huebner RJ, Gilmore LK, Parrott
RH and Ward TG: Isolation of a cytopathogenic agent from human
adenoids undergoing spontaneous degeneration in tissue culture.
Proc Soc Exp Biol Med. 84:570–573. 1953. View Article : Google Scholar : PubMed/NCBI
|
|
240
|
Trentin JJ, Yabe Y and Taylor G: The quest
for human cancer viruses. Science. 137:835–841. 1962. View Article : Google Scholar : PubMed/NCBI
|
|
241
|
Javier RT: Adenovirus type 9 E4 open
reading frame 1 encodes a transforming protein required for the
production of mammary tumors in rats. J Virol. 68:3917–3924. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
242
|
Sanchez-Prieto R, de Alava E, Palomino T,
Guinea J, Fernandez V, Cebrian S, LLeonart M, Cabello P, Martin P,
San Roman C, et al: An association between viral genes and human
oncogenic alterations: The adenovirus E1A induces the Ewing tumor
fusion transcript EWS-FLI1. Nat Med. 5:1076–1079. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
243
|
Wang GL, Jiang BH, Rue EA and Semenza GL:
Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS
heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci
USA. 92:5510–5514. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
244
|
Semenza GL: Hypoxia-inducible factor 1:
Master regulator of O2 homeostasis. Curr Opin Genet Dev. 8:588–594.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
245
|
Vaupel P and Mayer A: Hypoxia in cancer:
Significance and impact on clinical outcome. Cancer Metastasis Rev.
26:225–239. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
246
|
Sui H, Fan S, Liu W, Li Y, Zhang X, Du Y
and Bao H: LINC00028 regulates the development of TGFβ1-treated
human tenon capsule fibroblasts by targeting miR-204-5p. Biochem
Biophys Res Commun. Feb 19–2020.(Epub ahead of print). View Article : Google Scholar
|
|
247
|
Wittstatt J, Weider M, Wegner M and
Reiprich S: MicroRNA miR-204 regulates proliferation and
differentiation of oligodendroglia in culture. Glia. 68:2015–2027.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
248
|
Zhang J, Su M and Yin Z: Construction of
inflammatory directed polymer micelles and its application in acute
lung injury. AAPS PharmSciTech. 21:2172020. View Article : Google Scholar : PubMed/NCBI
|
|
249
|
Wang S, Liu Z, Wang L and Zhang X:
NF-kappaB signaling pathway, inflammation and colorectal cancer.
Cell Mol Immunol. 6:327–334. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
250
|
Engelman JA, Luo J and Cantley LC: The
evolution of phosphatidylinositol 3-kinases as regulators of growth
and metabolism. Nat Rev Genet. 7:606–619. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
251
|
Malumbres M: Cyclin-dependent kinases.
Genome Biol. 15:1222014. View
Article : Google Scholar : PubMed/NCBI
|
|
252
|
Greer EL and Brunet A: FOXO transcription
factors at the interface between longevity and tumor suppression.
Oncogene. 24:7410–7425. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
253
|
Katoh M and Katoh M: Human FOX gene family
(Review). Int J Oncol. 25:1495–1500. 2004.PubMed/NCBI
|
|
254
|
Koranda M, Schleiffer A, Endler L and
Ammerer G: Forkhead-like transcription factors recruit Ndd1 to the
chromatin of G2/M-specific promoters. Nature. 406:94–98. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
255
|
Pic A, Lim FL, Ross SJ, Veal EA, Johnson
AL, Sultan MR, West AG, Johnston LH, Sharrocks AD and Morgan BA:
The forkhead protein Fkh2 is a component of the yeast cell cycle
transcription factor SFF. EMBO J. 19:3750–3761. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
256
|
Kumar R, Reynolds DM, Shevchenko A,
Shevchenko A, Goldstone SD and Dalton S: Forkhead transcription
factors, Fkh1p and Fkh2p, collaborate with Mcm1p to control
transcription required for M-phase. Curr Biol. 10:896–906. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
257
|
Ho KK, Myatt SS and Lam EW: A number of
forks in the path: Cycling with FoxO. Oncogene. 27:2300–2311. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
258
|
Laoukili J, Stahl M and Medema RH: FoxM1:
At the crossroads of ageing and cancer. Biochim Biophys Acta.
1775:92–102. 2007.PubMed/NCBI
|
|
259
|
Yan J, Xu L, Crawford G, Wang Z and
Burgess SM: The forkhead transcription factor FoxI1 remains bound
to condensed mitotic chromosomes and stably remodels chromatin
structure. Mol Cell Biol. 26:155–168. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
260
|
Liang J and Shang Y: Estrogen and cancer.
Annu Rev Physiol. 75:225–240. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
261
|
Douglas CC, Johnson SA and Arjmandi BH:
Soy and its isoflavones: The truth behind the science in breast
cancer. Anticancer Agents Med Chem. 13:1178–1187. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
262
|
Eroles P, Bosch A, Pérez-Fidalgo JA and
Lluch A: Molecular biology in breast cancer: Intrinsic subtypes and
signaling pathways. Cancer Treat Rev. 38:698–707. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
263
|
Nestal de Moraes G, Khongkow P, Gong C,
Yao S, Gomes AR, Ji Z, Kandola N, Delbue D, Man EP, Khoo US, et al:
Forkhead box K2 modulates epirubicin and paclitaxel sensitivity
through FOXO3a in breast cancer. Oncogenesis. 4:e1672015.
View Article : Google Scholar : PubMed/NCBI
|
|
264
|
Zhang Y, Wang Y, Zhao G, Tanner EJ, Adli M
and Matei D: FOXK2 promotes ovarian cancer stemness by regulating
the unfolded protein response pathway. J Clin Invest.
132:e1515912022. View Article : Google Scholar : PubMed/NCBI
|
|
265
|
Amin ARMR, Karpowicz PA, Carey TE, Arbiser
J, Nahta R, Chen ZG, Dong JT, Kucuk O, Khan GN, Huang GS, et al:
Evasion of anti-growth signaling: A key step in tumorigenesis and
potential target for treatment and prophylaxis by natural
compounds. Semin Cancer Biol. 35 (Suppl 1):S55–S77. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
266
|
Milella M, Falcone I, Conciatori F, Cesta
Incani U, Del Curatolo A, Inzerilli N, Nuzzo CM, Vaccaro V, Vari S,
Cognetti F and Ciuffreda L: PTEN: Multiple functions in human
malignant tumors. Front Oncol. 5:242015. View Article : Google Scholar : PubMed/NCBI
|
|
267
|
Trinquand A, Tanguy-Schmidt A, Ben
Abdelali R, Lambert J, Beldjord K, Lengliné E, De Gunzburg N,
Payet-Bornet D, Lhermitte L, Mossafa H, et al: Toward a
NOTCH1/FBXW7/RAS/PTEN-based oncogenetic risk classification of
adult T-cell acute lymphoblastic leukemia: A group for research in
adult acute lymphoblastic leukemia study. J Clin Oncol.
31:4333–4342. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
268
|
Tesio M, Trinquand A, Macintyre E and
Asnafi V: Oncogenic PTEN functions and models in T-cell
malignancies. Oncogene. 35:3887–3896. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
269
|
Liu Y, Easton J, Shao Y, Maciaszek J, Wang
Z, Wilkinson MR, McCastlain K, Edmonson M, Pounds SB, Shi L, et al:
The genomic landscape of pediatric and young adult T-lineage acute
lymphoblastic leukemia. Nat Genet. 49:1211–1218. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
270
|
Wu W, Chen Y, Ye S, Yang H, Yang J and
Quan J: Transcription factor forkhead box K1 regulates miR-32
expression and enhances cell proliferation in colorectal cancer.
Oncol Lett. 21:4072021. View Article : Google Scholar : PubMed/NCBI
|
|
271
|
Wu W, Tan W, Ye S, Zhou Y and Quan J:
Analysis of the promoter region of the human miR-32 gene in
colorectal cancer. Oncol Lett. 17:3743–3750. 2019.PubMed/NCBI
|
|
272
|
Opel D, Schnaiter A, Dodier D, Jovanovic
M, Gerhardinger A, Idler I, Mertens D, Bullinger L, Stilgenbauer S
and Fulda S: Targeting inhibitor of apoptosis proteins by Smac
mimetic elicits cell death in poor prognostic subgroups of chronic
lymphocytic leukemia. Int J Cancer. 137:2959–2970. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
273
|
Mergny JL, Lacroix L, Teulade-Fichou MP,
Hounsou C, Guittat L, Hoarau M, Arimondo PB, Vigneron JP, Lehn JM,
Riou JF, et al: Telomerase inhibitors based on quadruplex ligands
selected by a fluorescence assay. Proc Natl Acad Sci USA.
98:3062–3067. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
274
|
Yin XM, Oltvai ZN and Korsmeyer SJ: BH1
and BH2 domains of Bcl-2 are required for inhibition of apoptosis
and heterodimerization with Bax. Nature. 369:321–323. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
275
|
Youle RJ and Strasser A: The BCL-2 protein
family: Opposing activities that mediate cell death. Nat Rev Mol
Cell Biol. 9:47–59. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
276
|
Asnaghi L, Calastretti A, Bevilacqua A,
D'Agnano I, Gatti G, Canti G, Delia D, Capaccioli S and Nicolin A:
Bcl-2 phosphorylation and apoptosis activated by damaged
microtubules require mTOR and are regulated by Akt. Oncogene.
23:5781–5791. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
277
|
Van Der Heide LP, Hoekman MF and Smidt MP:
The ins and outs of FoxO shuttling: Mechanisms of FoxO
translocation and transcriptional regulation. Biochem J.
380:297–309. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
278
|
Folkman J: Angiogenesis in cancer,
vascular, rheumatoid and other disease. Nat Med. 1:27–31. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
279
|
Folkman J: What is the evidence that
tumors are angiogenesis dependent? J Natl Cancer Inst. 82:4–6.
1990. View Article : Google Scholar : PubMed/NCBI
|
|
280
|
Baeriswyl V and Christofori G: The
angiogenic switch in carcinogenesis. Semin Cancer Biol. 19:329–337.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
281
|
Cao Y: Antiangiogenic cancer therapy.
Semin Cancer Biol. 14:139–145. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
282
|
Bergers G and Benjamin LE: Tumorigenesis
and the angiogenic switch. Nat Rev Cancer. 3:401–410. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
283
|
Song Y, Zeng S, Zheng G, Chen D, Li P,
Yang M, Luo K, Yin J, Gu Y, Zhang Z, et al: FOXO3a-driven miRNA
signatures suppresses VEGF-A/NRP1 signaling and breast cancer
metastasis. Oncogene. 40:777–790. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
284
|
Karaman S, Leppänen VM and Alitalo K:
Vascular endothelial growth factor signaling in development and
disease. Development. 145:dev1510192018. View Article : Google Scholar : PubMed/NCBI
|
|
285
|
Ellis LM and Hicklin DJ: VEGF-targeted
therapy: Mechanisms of anti-tumour activity. Nat Rev Cancer.
8:579–591. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
286
|
El Atat O, Fakih A and El-Sibai M: RHOG
activates RAC1 through CDC42 leading to tube formation in vascular
endothelial cells. Cells. 8:1712019. View Article : Google Scholar : PubMed/NCBI
|
|
287
|
Jin Z, Cheng X, Feng H, Kuang J, Yang W,
Peng C, Shen B and Qiu W: Apatinib inhibits angiogenesis via
suppressing Akt/GSK3β/ANG signaling pathway in anaplastic thyroid
cancer. Cell Physiol Biochem. 44:1471–1484. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
288
|
Wang S, Xiao Z, Hong Z, Jiao H, Zhu S,
Zhao Y, Bi J, Qiu J, Zhang D, Yan J, et al: FOXF1 promotes
angiogenesis and accelerates bevacizumab resistance in colorectal
cancer by transcriptionally activating VEGFA. Cancer Lett.
439:78–90. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
289
|
Sun T, Wang H, Li Q, Qian Z and Shen C:
Forkhead box protein k1 recruits TET1 to act as a tumor suppressor
and is associated with MRI detection. Jpn J Clin Oncol. 46:209–221.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
290
|
Bensinger SJ and Christofk HR: New aspects
of the Warburg effect in cancer cell biology. Semin Cell Dev Biol.
23:352–361. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
291
|
Palm W and Thompson CB: Nutrient
acquisition strategies of mammalian cells. Nature. 546:234–242.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
292
|
Cairns RA, Harris IS and Mak TW:
Regulation of cancer cell metabolism. Nat Rev Cancer. 11:85–95.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
293
|
Vander Heiden MG, Cantley LC and Thompson
CB: Understanding the Warburg effect: The metabolic requirements of
cell proliferation. Science. 324:1029–1033. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
294
|
Tamada M, Suematsu M and Saya H: Pyruvate
kinase M2: Multiple faces for conferring benefits on cancer cells.
Clin Cancer Res. 18:5554–5561. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
295
|
Waldhart AN, Dykstra H, Peck AS,
Boguslawski EA, Madaj ZB, Wen J, Veldkamp K, Hollowell M, Zheng B,
Cantley LC, et al: Phosphorylation of TXNIP by AKT mediates acute
influx of glucose in response to insulin. Cell Rep. 19:2005–2013.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
296
|
Sheth SS, Castellani LW, Chari S, Wagg C,
Thipphavong CK, Bodnar JS, Tontonoz P, Attie AD, Lopaschuk GD and
Lusis AJ: Thioredoxin-interacting protein deficiency disrupts the
fasting-feeding metabolic transition. J Lipid Res. 46:123–134.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
297
|
Luo W, Hu H, Chang R, Zhong J, Knabel M,
O'Meally R, Cole RN, Pandey A and Semenza GL: Pyruvate kinase M2 is
a PHD3-stimulated coactivator for hypoxia-inducible factor 1. Cell.
145:732–744. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
298
|
Denko NC: Hypoxia, HIF1 and glucose
metabolism in the solid tumour. Nat Rev Cancer. 8:705–713. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
299
|
Takamura A, Komatsu M, Hara T, Sakamoto A,
Kishi C, Waguri S, Eishi Y, Hino O, Tanaka K and Mizushima N:
Autophagy-deficient mice develop multiple liver tumors. Genes Dev.
25:795–800. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
300
|
Sun T, Li X, Zhang P, Chen WD, Zhang HL,
Li DD, Deng R, Qian XJ, Jiao L, Ji J, et al: Acetylation of beclin
1 inhibits autophagosome maturation and promotes tumour growth. Nat
Commun. 6:72152015. View Article : Google Scholar : PubMed/NCBI
|
|
301
|
Kimmelman AC and White E: Autophagy and
tumor metabolism. Cell Metab. 25:1037–1043. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
302
|
Nakatogawa H, Suzuki K, Kamada Y and
Ohsumi Y: Dynamics and diversity in autophagy mechanisms: Lessons
from yeast. Nat Rev Mol Cell Biol. 10:458–467. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
303
|
Kim J, Kim YC, Fang C, Russell RC, Kim JH,
Fan W, Liu R, Zhong Q and Guan KL: Differential regulation of
distinct Vps34 complexes by AMPK in nutrient stress and autophagy.
Cell. 152:290–303. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
304
|
Lambert SA, Jolma A, Campitelli LF, Das
PK, Yin Y, Albu M, Chen X, Taipale J, Hughes TR and Weirauch MT:
The human transcription factors. Cell. 172:650–665. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
305
|
Reiter F, Wienerroither S and Stark A:
Combinatorial function of transcription factors and cofactors. Curr
Opin Genet Dev. 43:73–81. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
306
|
Wunderlich Z and Mirny LA: Different gene
regulation strategies revealed by analysis of binding motifs.
Trends Genet. 25:434–440. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
307
|
Kuroyanagi H: Fox-1 family of RNA-binding
proteins. Cell Mol Life Sci. 66:3895–3907. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
308
|
Morgunova E and Taipale J: Structural
perspective of cooperative transcription factor binding. Curr Opin
Struct Biol. 47:1–8. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
309
|
Klemm SL, Shipony Z and Greenleaf WJ:
Chromatin accessibility and the regulatory epigenome. Nat Rev
Genet. 20:207–220. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
310
|
Iwafuchi-Doi M and Zaret KS: Pioneer
transcription factors in cell reprogramming. Genes Dev.
28:2679–2692. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
311
|
Soufi A, Garcia MF, Jaroszewicz A, Osman
N, Pellegrini M and Zaret KS: Pioneer transcription factors target
partial DNA motifs on nucleosomes to initiate reprogramming. Cell.
161:555–568. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
312
|
Swinstead EE, Miranda TB, Paakinaho V,
Baek S, Goldstein I, Hawkins M, Karpova TS, Ball D, Mazza D, Lavis
LD, et al: Steroid receptors reprogram FoxA1 occupancy through
dynamic chromatin transitions. Cell. 165:593–605. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
313
|
Hughes AL, Jin Y, Rando OJ and Struhl K: A
functional evolutionary approach to identify determinants of
nucleosome positioning: A unifying model for establishing the
genome-wide pattern. Mol Cell. 48:5–15. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
314
|
Struhl K and Segal E: Determinants of
nucleosome positioning. Nat Struct Mol Biol. 20:267–273. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
315
|
Swinstead EE, Paakinaho V, Presman DM and
Hager GL: Pioneer factors and ATP-dependent chromatin remodeling
factors interact dynamically: A new perspective: Multiple
transcription factors can effect chromatin pioneer functions
through dynamic interactions with ATP-dependent chromatin
remodeling factors. Bioessays. 38:1150–1157. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
316
|
Zhu F, Farnung L, Kaasinen E, Sahu B, Yin
Y, Wei B, Dodonova SO, Nitta KR, Morgunova E, Taipale M, et al: The
interaction landscape between transcription factors and the
nucleosome. Nature. 562:76–81. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
317
|
Iwafuchi-Doi M and Zaret KS: Cell fate
control by pioneer transcription factors. Development.
143:1833–1837. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
318
|
Allis CD and Jenuwein T: The molecular
hallmarks of epigenetic control. Nat Rev Genet. 17:487–500. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
319
|
Dann GP, Liszczak GP, Bagert JD, Müller
MM, Nguyen UTT, Wojcik F, Brown ZZ, Bos J, Panchenko T, Pihl R, et
al: ISWI chromatin remodellers sense nucleosome modifications to
determine substrate preference. Nature. 548:607–611. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
320
|
Iwafuchi-Doi M, Donahue G, Kakumanu A,
Watts JA, Mahony S, Pugh BF, Lee D, Kaestner KH and Zaret KS: The
pioneer transcription factor FoxA maintains an accessible
nucleosome configuration at enhancers for tissue-specific gene
activation. Mol Cell. 62:79–91. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
321
|
Iwafuchi M, Cuesta I, Donahue G, Takenaka
N, Osipovich AB, Magnuson MA, Roder H, Seeholzer SH, Santisteban P
and Zaret KS: Gene network transitions in embryos depend upon
interactions between a pioneer transcription factor and core
histones. Nat Genet. 52:418–427. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
322
|
Cirillo LA, Lin FR, Cuesta I, Friedman D,
Jarnik M and Zaret KS: Opening of compacted chromatin by early
developmental transcription factors HNF3 (FoxA) and GATA-4. Mol
Cell. 9:279–289. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
323
|
Shim EY, Woodcock C and Zaret KS:
Nucleosome positioning by the winged helix transcription factor
HNF3. Genes Dev. 12:5–10. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
324
|
Chen J, Zhang Z, Li L, Chen BC, Revyakin
A, Hajj B, Legant W, Dahan M, Lionnet T, Betzig E, et al:
Single-molecule dynamics of enhanceosome assembly in embryonic stem
cells. Cell. 156:1274–1285. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
325
|
Gebhardt JC, Suter DM, Roy R, Zhao ZW,
Chapman AR, Basu S, Maniatis T and Xie XS: Single-molecule imaging
of transcription factor binding to DNA in live mammalian cells. Nat
Methods. 10:421–426. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
326
|
Mazza D, Abernathy A, Golob N, Morisaki T
and McNally JG: A benchmark for chromatin binding measurements in
live cells. Nucleic Acids Res. 40:e1192012. View Article : Google Scholar : PubMed/NCBI
|
|
327
|
Morisaki T, Müller WG, Golob N, Mazza D
and McNally JG: Single-molecule analysis of transcription factor
binding at transcription sites in live cells. Nat Commun.
5:44562014. View Article : Google Scholar : PubMed/NCBI
|
|
328
|
Marchive C, Roudier F, Castaings L,
Bréhaut V, Blondet E, Colot V, Meyer C and Krapp A: Nuclear
retention of the transcription factor NLP7 orchestrates the early
response to nitrate in plants. Nat Commun. 4:17132013. View Article : Google Scholar : PubMed/NCBI
|
|
329
|
Rey G, Cesbron F, Rougemont J, Reinke H,
Brunner M and Naef F: Genome-wide and phase-specific DNA-binding
rhythms of BMAL1 control circadian output functions in mouse liver.
PLoS Biol. 9:e10005952011. View Article : Google Scholar : PubMed/NCBI
|
|
330
|
Futreal PA, Coin L, Marshall M, Down T,
Hubbard T, Wooster R, Rahman N and Stratton MR: A census of human
cancer genes. Nat Rev Cancer. 4:177–183. 2004. View Article : Google Scholar : PubMed/NCBI
|
